Abbott Point of Care
16
3
6
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department
Role: collaborator
Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population
Role: lead
Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens
Role: lead
Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Specimens
Role: lead
Precision Study Measuring Potassium (K) in Capillary Specimens
Role: lead
Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) in Blood
Role: lead
Evaluation of the Abbott i-STAT TBI Biomarker Test
Role: collaborator
Abbott i-STAT High Sensitivity Troponin I Study
Role: lead
Clinical Evaluation of the i-STAT TBI Test
Role: lead
The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study
Role: collaborator
Mbarara Acute Heart Failure Registry
Role: collaborator
Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples
Role: lead
Early Point-Of-Care Blood Tests, ECG & X-rays in the Emergency Department
Role: collaborator
Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study)
Role: collaborator
Validation of Early Warning Score & Lactate in Prehospital Screening
Role: collaborator
Myocardial Injury is Not Related to Training Levels Among Recreational Participants in the Silicon Valley Marathon
Role: collaborator
All 16 trials loaded